BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
103 hedge funds and large institutions have $730M invested in Blueprint Medicines in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
29% more capital invested
Capital invested by funds: $567M → $730M (+$163M)
18% more funds holding
Funds holding: 87 → 103 (+16)
58% less call options, than puts
Call options by funds: $378K | Put options by funds: $896K
Holders
103
Holding in Top 10
7
Calls
$378K
Puts
$896K
Top Buyers
| 1 | +$45.6M | |
| 2 | +$22.4M | |
| 3 | +$15.2M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$13.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.8M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$5.22M | |
| 3 | -$4.35M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$2.39M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.44M |